SCHEMBL9955539

SCHEMBL9955539

C=CCCCCCCC=CC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.58
ABCC4 O15439 1/20 0.58
TBXAS1 P24557 3/20 0.46
PTPN1 P18031 1/20 0.46
LMNA P02545 3/20 0.45
ALDH1A1 P00352 2/20 0.45
USP2 O75604 1/20 0.43
CYP3A4 P08684 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GABRR1 P24046 2/20 0.42
GABRR2 P28476 2/20 0.42
BLM P54132 2/20 0.42
TSHR P16473 2/20 0.42
GABRR3 A8MPY1 1/20 0.42
APEX1 P27695 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LPAR2 Q9HBW0 1/20 0.41
LPAR3 Q9UBY5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27896983 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL9281262 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL27957677 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL2491627 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL2854551 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL5378939 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL5378935 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL2854557 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL15284588 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL9735318 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225825-A1 POLY-3-HYDROXYALKANOATES HAVING VINYL MOIETIES AND METHOD OF PRODUCING SUCH Polyferm Canada Inc. (CA) 2023-08-16 EP disclosed
WO-2022074456-A1 POLY-3-HYDROXYALKANOATES HAVING VINYL MOIETIES AND METHOD OF PRODUCING SUCH POLYFERM CANADA INC. (CA) 2022-04-14 WO disclosed
EP-2970093-B1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2018-12-12 EP disclosed
US-9908837-B2 Method for preparing (meth)acrylates of biobased alcohols and polymers thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-03-06 US disclosed
CN-107613767-A Cooperate with anticorrosive composite ISP投资有限公司 2018-01-19 CN disclosed
US-20160009628-A1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2016-01-14 US disclosed
US-9102774-B2 Polymers derived from secondary alkyl (meth)acrylates 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-08-11 US disclosed
EP-2655451-B1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES CO (US) 2015-03-11 EP disclosed
EP-2655451-A1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M Innovative Properties Company (US) 2013-10-30 EP disclosed
US-20130260149-A1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES COMPANY 2013-10-03 US disclosed
WO-2012088126-A1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009628-A1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF ADH1A, ADH1C, ADH5 MAPT 2551/4885ABCC4 4734/4885TBXAS1 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.